Workflow
CENTEK(000931)
icon
Search documents
中 关 村: 关于召开2025年第五次临时股东会的通知
Zheng Quan Zhi Xing· 2025-08-04 16:22
关于召开 2025 年第五次临时股东会的通知 共 6 页 证券代码:000931 证券简称:中关村 公告编号:2025-085 北京中关村科技发展(控股)股份有限公司 关于召开 2025 年第五次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 一、召开会议的基本情况 公司第九届董事会 2025 年度第四次临时会议审议通过《关于召开 2025 年 第五次临时股东会的议案》。 有关法律法规、深交所业务规则和公司章程等的规定。 (1)现场会议时间:2025 年 8 月 20 日下午 14:50; (2)网络投票时间:2025 年 8 月 20 日。 其中,通过深圳证券交易所交易系统进行网络投票的时间为:2025 年 8 月 通过深圳证券交易所互联网投票系统投票的时间为 2025 年 8 月 20 日 9:15 至 15:00 期间的任意时间。 本次股东会采用现场表决与网络投票相结合的表决方式。 (1)现场表决方式:股东本人出席现场会议或者通过授权委托书委托他人 出席现场会议进行表决。 (2)网络投票方式:公司将通过深圳证券交易所交易系统和互联网投票 ...
中关村科技租赁(01601):杨鹏艳董事会秘书及财务负责人的任职资格获核准
智通财经网· 2025-08-04 14:57
Group 1 - The company, Zhongguancun Science and Technology Leasing, has received approval from the Beijing Local Financial Supervision Administration for a change in senior management [1] - Ms. Yang Pengyan has been approved as the company's board secretary and financial officer, effective from August 4, 2025 [1] - Mr. Huang Wenxian's resignation will also take effect on the same date, August 4, 2025 [1]
中关村科技租赁:杨鹏艳董事会秘书及财务负责人的任职资格获核准
Zhi Tong Cai Jing· 2025-08-04 14:56
Group 1 - The company, Zhongguancun Science and Technology Leasing (01601), has received approval from the Beijing Local Financial Supervision Administration for a change in senior management [1] - Ms. Yang Pengyan has been approved to serve as the company's board secretary and financial officer, effective from August 4, 2025 [1] - Mr. Huang Wen's resignation from his position will also take effect on August 4, 2025 [1]
中关村科技租赁(01601.HK):杨鹏艳董事会秘书及财务负责人任职资格获核准
Ge Long Hui· 2025-08-04 14:30
格隆汇8月4日丨中关村科技租赁(01601.HK)公告,公司于近日收到北京市地方金融管理局下发的《北京 市地方金融管理局关于同意中关村科技租赁股份有限公司变更高级管理人员的批覆》(京金局发 [2025]207号),核准杨鹏艳公司董事会秘书及财务负责人的任职资格。杨鹏艳的任职及黄闻的辞任于 2025年8月4日正式生效。 ...
中关村:第九届董事会2025年度第四次临时会议决议公告
Zheng Quan Ri Bao· 2025-08-04 13:17
Core Points - Zhongguancun announced the approval of multiple proposals during the fourth temporary meeting of the ninth board of directors for the fiscal year 2025, including a guarantee for a financing credit application of 46 million yuan by Shandong Huasu to Bank of Communications [2] Summary by Category - **Company Actions** - Zhongguancun's board approved a proposal to provide a guarantee for a financing credit application of 46 million yuan [2] - **Financial Implications** - The financing credit application is aimed at supporting Shandong Huasu's operations [2] - **Corporate Governance** - The decision was made during the fourth temporary meeting of the ninth board of directors, indicating active governance and oversight [2]
中关村:8月20日将召开2025年第五次临时股东会
Zheng Quan Ri Bao Wang· 2025-08-04 12:40
证券日报网讯 8月4日晚间,中关村(000931)发布公告称,公司将于2025年8月20日召开2025年第五次 临时股东会。本次股东会将审议《关于山东中关村为山东华素向交通银行申请4,600万元融资授信提供 担保的议案》等多项议案。 ...
中关村:8月4日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-04 11:27
Group 1 - The company Zhongguancun (SZ 000931) held its fourth temporary board meeting for the year 2025 on August 4, 2025, in Beijing, discussing the proposal for the fifth temporary shareholders' meeting [2] - For the fiscal year 2024, the company's revenue composition is as follows: Biopharmaceuticals accounted for 74.96%, Concrete for 17.48%, Elderly Health for 4.94%, and Others for 2.62% [2]
中关村为中实通达500万融资授信提供担保
Sou Hu Cai Jing· 2025-08-04 11:17
Core Viewpoint - The company has approved a guarantee for its subsidiary, Zhongshitongda, to secure a financing credit of up to 5 million RMB from Beijing Rural Commercial Bank, backed by real estate assets valued at approximately 24.88 million RMB [1][2]. Group 1: Company Financials - Zhongshitongda, a wholly-owned subsidiary of the company, has total assets of 26,000,731.25 RMB and total liabilities of 24,705,185.73 RMB as of December 31, 2024, resulting in a debt-to-asset ratio of 95.02% [1]. - As of March 31, 2025, Zhongshitongda's total assets decreased to 20,080,421.49 RMB with total liabilities of 18,784,260.97 RMB, leading to a debt-to-asset ratio of 93.55% [1]. Group 2: Collateral and Guarantee Details - The collateral for the financing consists of commercial real estate with a total area of 587.33 square meters and a book value of 5,331,000 RMB as of March 31, 2025 [2]. - The guarantee includes joint liability and mortgage guarantees, with a guarantee period extending three years beyond the debt fulfillment date [2]. - After this guarantee, the total guarantee amount for the company and its subsidiaries will reach 92.4 million RMB, which is 58.17% of the latest audited net assets and 24.89% of total assets [2].
中关村:公司和山东中关村为山东华素3000万融资授信提供担保
Sou Hu Cai Jing· 2025-08-04 11:17
担保协议中,担保方式为连带责任保证担保,担保期限为主合同项下债务履行期限届满之日起三年,担 保范围包括主合同项下本金余额等多种费用,担保金额为3,000万元人民币,不过有关协议尚未签署。 此项业务用于山东华素补充流动资金,其还款来源为经营收入。 另外,本次担保后,公司及其控股子公司担保额度总金额为92,400万元,占公司最近一期经审计净资产 和总资产的比例分别为58.17%和24.89%。截至本公告披露日,公司及控股子公司对外担保总余额为 52,783万元,占最近一期经审计净资产的比例为33.23%,未发生逾期担保等不良情况。 山东华素制药有限公司向日照银行股份有限公司威海经济技术开发区支行申请额度不超过3,000万元人 民币的融资授信,期限不超过1年。此前的融资授信即将到期,此次仍由公司与公司全资子公司山东中 关村医药科技发展有限公司共同提供连带责任保证担保,并由山东华素以其名下的一项发明专利及九项 实用新型专利的专利权提供质押担保。经评估,这些专利权于2025年3月31日的评估值为4,079.00万元人 民币,山东华素也已出具书面《反担保书》。 山东华素基本情况方面,其为有限责任公司,注册地址在威海市羊亭 ...
中关村:四环医药为多多药业1000万元融资授信提供担保
Jin Rong Jie· 2025-08-04 10:55
Group 1 - The company Beijing Zhongguancun Technology Development (Holding) Co., Ltd. announced a board meeting to approve a financing guarantee for Duoduo Pharmaceutical to apply for a credit facility of up to 10 million RMB from Jiamusi Rural Credit Cooperative [1] - Duoduo Pharmaceutical, a subsidiary of Beijing Zhongguancun Sihuan Pharmaceutical Development Co., Ltd., plans to use the financing for normal operational cash flow needs, with repayment sourced from sales revenue [2] - The total amount of guarantees provided by the company and its subsidiaries after this transaction will be 92.4 million RMB, which represents 58.17% of the latest audited net assets and 24.89% of total assets [2] Group 2 - As of the announcement date, the total external guarantee balance of the company and its subsidiaries is 52.783 million RMB, accounting for 33.23% of the latest audited net assets, with no overdue guarantees reported [2] - Duoduo Pharmaceutical has a registered capital of 23.3425 million RMB and reported total assets of approximately 756.76 million RMB and total liabilities of approximately 247.01 million RMB as of December 31, 2024 [1]